PFM Health Sciences’s Goldman Sachs GS Stock Holding History

PFM Health Sciences’s Portfolio GS Stock Details GS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-47,320	Closed	-$9.81M	–	67
2019 Q3	$9.81M	Buy	+47,320	New	+$9.9M	0.29%	60

Other funds holding GS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PFM Health Sciences's GS Position: Q4 2019 in Review

PFM Health Sciences sold out of Goldman Sachs (GS) in Q4 2019, closing a stake of 47,320 shares — an estimated $9.81M sold.

PFM Health Sciences first reported a position in GS in Q3 2019 and held it in 1 quarter. The position peaked at $9.81M in Q3 2019. 1,374 funds tracked by Wall St. Rank hold GS as of Q4 2019.

PFM Health Sciences reported no remaining Goldman Sachs position as of Q4 2019 after selling out during the quarter.
PFM Health Sciences sold 47,320 Goldman Sachs shares in Q4 2019, an estimated $9.81M.
PFM Health Sciences first reported a position in Goldman Sachs in Q3 2019 and held it in 1 quarter.
PFM Health Sciences's Goldman Sachs position peaked at $9.81M in Q3 2019.
1,374 funds tracked by Wall St. Rank held Goldman Sachs as of Q4 2019.

Based on PFM Health Sciences's 13F filing for Q4 2019, filed 14 Feb 2020.